Markets:

Overview

News

Currencies

International

Treasuries

ResMed Inc. Common Stock (NY:RMD)

249.19 +3.83 (+1.56%)

Official Closing Price Updated: 7:00 PM EST, Jan 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ResMed Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

These S&P500 stocks are gapping in today's session ↗

August 27, 2025

Let's take a look at the S&P500 stocks that are experiencing notable price gaps in today's session on Wednesday. Discover the gap up and gap down stocks in the S&P500 index.

Via Chartmill

Obstructive Sleep Apnea Expected to Affect Nearly 77 million U.S. Adults by 2050, New Resmed Study Finds

August 27, 2025

Published in The Lancet Respiratory Medicine, research reveals sharp rise in OSA, especially among women, highlighting the need for earlier diagnosis, preventative strategies, and personalized care

From Resmed, Inc.

Via GlobeNewswire

1 Mooning Stock to Target This Week and 2 We Brush Off

August 26, 2025

Each stock in this article is trading near its 52-week high. These elevated prices usually indicate some degree of investor confidence, business improvements, or favorable market conditions.

Via StockStory

Meta, Microsoft Power Wall Street To New Records Despite Inflation Jump: What's Moving Markets Thursday? ↗

July 31, 2025

A post-earnings surge in Meta Platforms Inc. (NASDAQ:META) and Microsoft Corp.

Via Benzinga

Topics Economy

Earnings Scheduled For July 31, 2025 ↗

July 31, 2025

Via Benzinga

Resmed Strengthens Innovation Leadership with Dual Red Dot Design Awards and 10,000 Patents and Designs

August 21, 2025

Milestones underscore Resmed’s leadership and commitment to delivering life-changing health technology that people love

From Resmed, Inc.

Via GlobeNewswire

Resmed Announces Election of Nicole Mowad-Nassar to Board of Directors and Upcoming Retirement of Rich Sulpizio

August 18, 2025

From Resmed, Inc.

Via GlobeNewswire

RMD Q2 Deep Dive: Margin Expansion and Product Innovation Drive Outperformance

August 12, 2025

Medical device company ResMed (NYSE:RMD) reported Q2 CY2025 results beating Wall Street’s revenue expectations, with sales up 10.2% year on year to $1.35 billion. Its non-GAAP profit of $2.55 per share...

Via StockStory

Topics Artificial Intelligence Economy

ResMed Inc (NYSE:RMD): A Strong Dividend Stock with Growth Potential and Financial Stability ↗

August 09, 2025

ResMed (RMD) offers a strong dividend with steady growth, backed by solid profitability and financial health, making it ideal for long-term income investors.

Via Chartmill

Discover the top S&P500 movers in Tuesday's pre-market session. ↗

August 05, 2025

Stay updated with the S&P500 stocks that are on the move in today's pre-market session.

Via Chartmill

ResMed RMD Q4 2025 Earnings Call Transcript ↗

August 04, 2025

Via The Motley Fool

Topics Earnings

Stay informed with the top movers within the S&P500 index on Monday. ↗

August 04, 2025

Curious about the S&P500 stocks that are in motion on Monday? Join us as we explore the top movers within the S&P500 index during today's session.

Via Chartmill

The Analyst Verdict: ResMed In The Eyes Of 8 Experts ↗

August 01, 2025

Via Benzinga

ResMed Analysts Increase Their Forecasts After Strong Q2 Earnings ↗

August 01, 2025

Via Benzinga

ResMed (RMD) Stock Is Up, What You Need To Know

August 01, 2025

Shares of medical device company ResMed (NYSE:RMD) jumped 3.1% in the afternoon session after the company reported strong fourth-quarter financial results that surpassed analyst estimates.

Via StockStory

Apple To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Friday ↗

August 01, 2025

Via Benzinga

ResMed (NYSE:RMD) Surprises With Q2 Sales

July 31, 2025

Medical device company ResMed (NYSE:RMD) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 10.2% year on year to $1.35 billion. Its non-GAAP profit of $2.55 per share was 3% above...

Via StockStory

Resmed Inc. (NYSE:RMD) Beats Q4 2025 Revenue and EPS Estimates Despite Muted Market Reaction ↗

July 31, 2025

Resmed Inc. (NYSE:RMD) beats Q4 2025 revenue and EPS estimates, reporting $1.35B and $2.55, respectively. Stock dips slightly amid muted market reaction despite strong growth and dividend hike.

Via Chartmill

Resmed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2025

July 31, 2025

From Resmed, Inc.

Via GlobeNewswire

ResMed (RMD) To Report Earnings Tomorrow: Here Is What To Expect

July 29, 2025

Medical device company ResMed (NYSE:RMD) will be reporting earnings this Thursday afternoon. Here’s what investors should know.

Via StockStory

Topics Artificial Intelligence

Analyst Expectations For ResMed's Future ↗

July 16, 2025

Via Benzinga

2 Reasons to Watch RMD and 1 to Stay Cautious

July 15, 2025

ResMed trades at $254.11 per share and has stayed right on track with the overall market, gaining 8.9% over the last six months. At the same time, the S&P 500 has returned 5.4%.

Via StockStory

Topics Government Stocks

Motley Fool Co-Founder David Gardner Reviews Stock Picks ↗

July 11, 2025

Via The Motley Fool

2 S&P 500 Stocks with Promising Prospects and 1 to Steer Clear Of

July 09, 2025

While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural...

Via StockStory

Topics Economy Stocks

Resmed to Report Fourth Quarter Fiscal 2025 Earnings on July 31, 2025

July 01, 2025

From Resmed, Inc.

Via GlobeNewswire

RESMED INC (NYSE:RMD) – A Strong Candidate for Quality Investors ↗

July 01, 2025

RESMED INC (NYSE:RMD) is a high-quality stock with strong revenue growth, exceptional ROIC, and solid cash flow, making it a standout pick for long-term investors.

Via Chartmill

2 Cash-Producing Stocks to Consider Right Now and 1 to Ignore

June 19, 2025

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.

Via StockStory

Looking Back on a Motley Fool Career ↗

June 17, 2025

Via The Motley Fool

ResMed: A Mixed Bag for Investors Amid Rising Competition ↗

June 10, 2025

Via The Motley Fool

RESMED INC (NYSE:RMD) – A Strong Contender for Quality Investors ↗

June 09, 2025

RESMED INC (NYSE:RMD) is a high-quality stock with strong profitability, low debt, and consistent growth, making it a candidate for long-term investors.

Via Chartmill

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.